Inhibition of ESCRT-III activates alternative pathways for protein degradation and secretion
Authors:
- 31 March 2026
- journal article
- Published by Elsevier in Neurochemistry International
- Vol. 196, 106153
Abstract
No abstract availableKeywords
Funding Information
- Takeda Science Foundation
- Japan Society for the Promotion of Science (19H05710)
This publication has 20 references indexed in Scilit:
- The lysosomal membrane protein LAMP2B mediates microlipophagy to target obesity-related disordersCell Reports, 2025
- Truncation mutation of CHMP2B disrupts late endosome function but reduces TDP-43 aggregation through HSP70 upregulationNeurochemistry International, 2025
- Bi-allelic variants in SNF8 cause a disease spectrum ranging from severe developmental and epileptic encephalopathy to syndromic optic atrophyThe American Journal of Human Genetics, 2024
- De Novo VPS4A Mutations Cause Multisystem Disease with Abnormal NeurodevelopmentThe American Journal of Human Genetics, 2020
- Truncating Mutations in UBAP1 Cause Hereditary Spastic ParaplegiaThe American Journal of Human Genetics, 2019
- Designed proteins induce the formation of nanocage-containing extracellular vesiclesNature, 2016
- The ESCRT machinery: new roles at new holesCurrent Opinion in Cell Biology, 2016
- CHMP1A encodes an essential regulator of BMI1-INK4A in cerebellar developmentNature Genetics, 2012
- Microautophagy of Cytosolic Proteins by Late EndosomesDevelopmental Cell, 2011
- Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementiaNature Genetics, 2005